Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.

Erin M BayleyKyle G MitchellNicolas ZhouChantale BernatchezMarie-Andrée ForgetCara L HaymakerWayne L HofstetterReza J MehranRavi RajaramDavid C RiceJack A RothBoris SepesiStephen G SwisherAra A VaporciyanGarrett L WalshRodabe N AmariaAmir A JazaeriMara B Antonoff

Published in: Journal of surgical oncology (2021)

Pulmonary TIL harvest is safe and feasible, without major postoperative events in our cohort. All patients were able to receive intended ACT infusion without delays. Therefore, thoracic surgeons should actively participate in ongoing ACT trials and aggressively seek to enroll patients on these protocols.

Keyphrases

end stage renal disease
newly diagnosed
pulmonary hypertension
peritoneal dialysis
spinal cord
patient reported outcomes
mesenchymal stem cells
bone marrow
smoking cessation